Cargando…
Oral tofacitinib citrate for recalcitrant cutaneous lupus
Autores principales: | Bonnardeaux, Evelyne, Dutz, Jan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792392/ https://www.ncbi.nlm.nih.gov/pubmed/35118185 http://dx.doi.org/10.1016/j.jdcr.2021.09.030 |
Ejemplares similares
-
Recalcitrant nodular scabies showing excellent response to tofacitinib: five case reports
por: Zhao, Yu-Kun, et al.
Publicado: (2023) -
New-onset autoantibody-mediated nephritis during ustekinumab therapy for psoriasis in patients with and without prior systemic lupus erythematosus
por: Al Khalili, Ayida, et al.
Publicado: (2019) -
Clinical response to oral tofacitinib in pediatric patients with alopecia areata
por: Youssef, Soundos, et al.
Publicado: (2022) -
Subacute cutaneous lupus erythematosus versus discoid lupus erythematosus: A challenging diagnosis
por: Kleitsch, Julianne, et al.
Publicado: (2023) -
Tofacitinib in recalcitrant scleritis: First case report from India
por: Pyare, Richa, et al.
Publicado: (2020)